Patents by Inventor Pål Aukrust

Pål Aukrust has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160377632
    Abstract: The present invention relates to diagnosis, classification and monitoring of atherosclerotic plaques in an individual using measurement of the concentration of CD36 in a body fluid and/or the plaque as such. The present invention also relates to diagnosing the burden of atherosclerotic plaques in an individual. Furthermore, the invention relates to a method for diagnosing stenosis caused by atherosclerotic plaques. Within the scope of the present invention are also methods for determining the treatment regime of an individual. Kits and oligonucleotides for use in the methods are claimed.
    Type: Application
    Filed: January 26, 2016
    Publication date: December 29, 2016
    Inventors: Aase Handberg, Bente Halvorsen, Pål Aukrust, Mona Skjelland
  • Publication number: 20140371089
    Abstract: The present invention relates to diagnosis, classification and monitoring of atherosclerotic plaques in an individual using measurement of the concentration of CD36 in a body fluid and/or the plaque as such. The present invention also relates to diagnosing the burden of atherosclerotic plaques in an individual. Furthermore, the invention relates to a method for diagnosing stenosis caused by atherosclerotic plaques. Within the scope of the present invention are also methods for determining the treatment regime of an individual. Kits and oligonucleotides for use in the methods are claimed.
    Type: Application
    Filed: June 26, 2014
    Publication date: December 18, 2014
    Inventors: Aase Handberg, Bente Halvorsen, Pål Aukrust, Mona Skjelland
  • Publication number: 20110212471
    Abstract: The present invention relates to diagnosis, classification and monitoring of atherosclerotic plaques in an individual using measurement of the concentration of CD36 in a body fluid and/or the plaque as such. The present invention also relates to diagnosing the burden of atherosclerotic plaques in an individual. Furthermore, the invention relates to a method for diagnosing stenosis caused by atherosclerotic plaques. Within the scope of the present invention are also methods for determining the treatment regime of an individual. Kits and oligonucleotides for use in the methods are claimed.
    Type: Application
    Filed: December 17, 2010
    Publication date: September 1, 2011
    Inventors: Aase Handberg, Bente Halvorsen, Pål Aukrust, Mona Skjelland
  • Patent number: 7790738
    Abstract: The present invention provides a method of treating or preventing a disorder typified by an immunodificiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluorophasphate. L-745337, rofecoxib, NS 398, SC 58125, etodolac, meloxicam, celecoxib or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: September 7, 2010
    Assignee: Lauras AS
    Inventors: Kjetil Taskén, Michel Moutschen, Souad Rahmouni-Piette, Einar Martin Aandahl, Pål Aukrust, Stig S. Frøland, Christian C. Johansson, Vidar Hansson, Jo Klaveness
  • Publication number: 20100105088
    Abstract: The present invention relates to diagnosis, classification and monitoring of atherosclerotic plaques in an individual using measurement of the concentration of CD36 in a body fluid and/or the plaque as such. The present invention also relates to diagnosing the burden of atherosclerotic plaques in an individual. Furthermore, the invention relates to a method for diagnosing stenosis caused by atherosclerotic plaques. Within the scope of the present invention are also methods for determining the treatment regime of an individual. Kits and oligonucleotides for use in the methods are claimed.
    Type: Application
    Filed: February 4, 2008
    Publication date: April 29, 2010
    Applicants: AARHUS UNIVERSITET, REGION MIDTJYLLAND, RIKSHOSPITALET HF
    Inventors: Aase Handberg, Bente Halvorsen, Pål Aukrust, Mona Skjelland
  • Patent number: 7192932
    Abstract: Pharmaceutical compositions useful for treating immunosuppressive disease and containing compounds capable of inhibiting cAMP-dependent protein kinase A (PKA) as well as use of the same, are described.
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: March 20, 2007
    Assignee: Lauras AS
    Inventors: Kjetil Taskén, Einar M. Aandahl, Pål Aukrust, Bjørn S. Skålhegg, Fredrik Müller, Stig Frøland, Vidar Hansson